GR3015822T3 - Stable preparation containing azelastine hydrochloride. - Google Patents

Stable preparation containing azelastine hydrochloride.

Info

Publication number
GR3015822T3
GR3015822T3 GR950400952T GR950400952T GR3015822T3 GR 3015822 T3 GR3015822 T3 GR 3015822T3 GR 950400952 T GR950400952 T GR 950400952T GR 950400952 T GR950400952 T GR 950400952T GR 3015822 T3 GR3015822 T3 GR 3015822T3
Authority
GR
Greece
Prior art keywords
azelastine hydrochloride
preparation containing
stable preparation
carbon atoms
fatty acid
Prior art date
Application number
GR950400952T
Other languages
English (en)
Inventor
Yutaka Morita
Noritosi Koyama
Sigemitu Ohsawa
Original Assignee
Asta Medica Ag
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag, Eisai Co Ltd filed Critical Asta Medica Ag
Publication of GR3015822T3 publication Critical patent/GR3015822T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
GR950400952T 1992-07-20 1995-04-17 Stable preparation containing azelastine hydrochloride. GR3015822T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21324392A JP3190441B2 (ja) 1992-07-20 1992-07-20 塩酸アゼラスチンを含有する安定な製剤

Publications (1)

Publication Number Publication Date
GR3015822T3 true GR3015822T3 (en) 1995-07-31

Family

ID=16635891

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400952T GR3015822T3 (en) 1992-07-20 1995-04-17 Stable preparation containing azelastine hydrochloride.

Country Status (8)

Country Link
US (1) US6117864A (el)
EP (1) EP0580074B1 (el)
JP (1) JP3190441B2 (el)
AT (1) ATE117207T1 (el)
DE (1) DE69300054T2 (el)
DK (1) DK0580074T3 (el)
ES (1) ES2068725T3 (el)
GR (1) GR3015822T3 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
AU2940100A (en) * 1999-03-11 2000-09-28 Saitama Daiichi Pharmaceutical Co., Ltd. Compositions for promoting percutaneous absorption
JP4643018B2 (ja) * 1999-04-13 2011-03-02 久光製薬株式会社 経皮吸収型製剤
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20030018085A1 (en) * 2001-05-11 2003-01-23 Raoof Araz A. Isostearic acid salts as permeation enhancers
EP1392272B1 (en) 2001-05-11 2014-08-06 Merrion Research III Limited Permeation enhancers
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
PT2522365T (pt) * 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
CA2648594C (en) 2006-04-07 2012-10-16 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
US20090280169A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of peptides and processes of preparation thereof
WO2011120033A1 (en) 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
US9254325B2 (en) 2010-10-28 2016-02-09 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbed preparation
KR101261230B1 (ko) * 2010-11-29 2013-05-07 한림제약(주) 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
AU2012204213A1 (en) 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP6545148B2 (ja) 2013-03-13 2019-07-17 フラットリー ディスカバリー ラブ，エルエルシー ピリダジノン化合物及び嚢胞性線維症の治療のための方法
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
CA2002299A1 (en) * 1988-11-10 1990-05-10 Eugene G. Drust Compositions for the transdermal delivery of buprenorphine salts
US5110814A (en) * 1989-01-11 1992-05-05 Asta Pharma Ag Azelastine and its salts used to combat psoriasis
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
DE69021511T2 (de) * 1989-11-14 1996-11-21 Beta Pharm Co Entzündungshemmende Arzneimittel zur äusserlichen Anwendung.

Also Published As

Publication number Publication date
US6117864A (en) 2000-09-12
ATE117207T1 (de) 1995-02-15
DK0580074T3 (da) 1995-04-10
JP3190441B2 (ja) 2001-07-23
EP0580074B1 (en) 1995-01-18
DE69300054D1 (de) 1995-03-02
DE69300054T2 (de) 1996-05-30
EP0580074A1 (en) 1994-01-26
ES2068725T3 (es) 1995-04-16
JPH0640949A (ja) 1994-02-15

Similar Documents

Publication Publication Date Title
GR3015822T3 (en) Stable preparation containing azelastine hydrochloride.
IE790210L (en) Alkylenediamine derivatives
TW341514B (en) Aqueous topical pharmaceutical compositions useful for exfoliation and prevention or treatment of acne
GB2308546A (en) Pharmaceutical compositions
GR3004845T3 (el)
SG46307A1 (en) New pyrazine derivatives the preparation and use thereof
HUT55002A (en) Process for producing pyrimidine -4,6-dicarboxylic acid-diamides and pharmaceutical compositions containing them as active components
JPS6413017A (en) Skin-beautifying cosmetic
EP0450527A3 (en) N-tris(hydroxymethyl)methylfatty acid amides and cosmetic compositions containing same
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
DE69507150D1 (de) Gelbildende präparate, die optisch angereicherte gelbildner enthalten
ES2000907A6 (es) Procedimiento de preparar compuestos 2-oxaisocefen microbiologicamente activos
JPS6413018A (en) Skin-beautifying cosmetic
ES8500269A1 (es) Procedimiento para la fabricacion de un derivado de azolcarboxamida n,n-subsitutida.
YU65800A (sh) Novi derivati oktahidro-6,10-diokso-6h-piridazino(1,2-a) (1,2)diazepin-1-karboksilne kiseline, njihov postupak dobijanja i njihova primena za dobijanje terapeutski aktivnih jedinjenja
GB1521181A (en) Ketolactones and their manufacture
AU5847386A (en) Derivatives of 1,1,2,2-tetramethyl-1,2-bis-(2-fluoro-4- hydroxphenyl)-ethane
HUT70961A (en) Pharmaceutical compositions containing gemfibrozyl and process for producing them
GB2175584A (en) Kojic acid derivatives and whitening cosmetics containing same
AU5170285A (en) Dihydrodithiazine derivatives
AU1032197A (en) New amino alcohol derivatives, processes for their production and pharmaceutical agents containing these compounds
ES477163A1 (es) Procedimiento para la preparacion de compuestos de acidos 4-(8x-6,11-dihidro-dibenzo- b.e. -tiepin-11-on-3-il)-4-oxobu- tiricos.
HUT73562A (en) Thiocarbamoyl-pyrazole derivatives, keto-carboxylic acid ester intermediates thereof, preparations thereof, using the pyrazole derivatives and microbicide compositions containing these compounds
ATE189383T1 (de) Schweisshemmende cremezusammensetzungen enthaltend triglycerid gelierungsmittel